EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Switch to bictegravir/emtricitabine/tenofovir alafenamide in people living with HIV aged 65 years or older: BICOLDER study – IMEA 057

Minh P Lê, Clotilde Allavena, Véronique Joly, Lambert Assoumou, Valentina Isernia, Faiza Ajana, Didier Neau, Diane Descamps, Charlotte Charpentier, Aïda Benalycherif, Bao Phung, Gilles Peytavin und 2 weitere

Journal of Infection and Public Health · 2025

DOI: 10.1016/j.jiph.2025.102946 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Infection and Public Health, 2025. Verfasst von Minh P Lê und 13 weiteren Autor:innen. Beteiligte Einrichtung: AP-HP, Hospital Bichat-Claude Bernard, Pharmacology Laboratory, IAME UMR 1137 INSERM, Université Paris Cité, France. Electronic address: minh.le@aphp…. Hauptthemen laut MEDLINE: Adenine, Anti-HIV Agents, Drug Substitution, Emtricitabine. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gilead Sciences Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdenineAnti-HIV AgentsDrug SubstitutionEmtricitabineHeterocyclic Compounds, 4 or More RingsHIV InfectionsTenofovirAgedFemaleHumansMaleAlanineDrug CombinationsDrug InteractionsHIV-1PiperazinesProspective StudiesPyridonesRNA, ViralTreatment OutcomeViral LoadAmidesHeterocyclic Compounds, 3-Ring

Stichwörter der Autor:innen

ARV strategyAged populationBictegravirComorbiditiesHIV

Substanzen

AdenineAlanineAnti-HIV AgentsbictegravirDrug CombinationsEmtricitabineHeterocyclic Compounds, 4 or More RingsPiperazinesPyridonesRNA, Viral

Autor:innen und Institutionen

  • AP-HP, Hospital Bichat-Claude Bernard, Pharmacology Laboratory, IAME UMR 1137 INSERM, Université Paris Cité, France. Electronic address: minh.le@aphp.fr.
  • Hotel Dieu Hospital, Infectious and Tropical Diseases Department, Nantes, France.
  • AP-HP, Hospital Bichat - Claude-Bernard, Infectious and Tropical Diseases Department, IAME UMR 1137 INSERM, Université Paris Cité, France.
  • Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France.
  • Gustave Dron Hospital, Infectious and tRopical Diseases Department, Tourcoing, France.
  • Pellegrin Hospital, Infectious and Tropical Diseases Department, Bordeaux, France.

Förderung

  • Gilead Sciences Inc

Zitieren

APA

Lê, M. P., Allavena, C., Joly, V., Assoumou, L., Isernia, V., Ajana, F., Neau, D., Descamps, D., Charpentier, C., Benalycherif, A., Phung, B., Peytavin, G., Landman, R., & BICOLDER-IMEA 057 study group (2025). Switch to bictegravir/emtricitabine/tenofovir alafenamide in people living with HIV aged 65 years or older: BICOLDER study – IMEA 057. Journal of Infection and Public Health. https://doi.org/10.1016/j.jiph.2025.102946

Vancouver

Lê MP, Allavena C, Joly V, Assoumou L, Isernia V, Ajana F, et al. Switch to bictegravir/emtricitabine/tenofovir alafenamide in people living with HIV aged 65 years or older: BICOLDER study – IMEA 057. Journal of Infection and Public Health. 2025. doi:10.1016/j.jiph.2025.102946

BibTeX
@article{L2025,
  author = {Lê, Minh P and Allavena, Clotilde and Joly, Véronique and Assoumou, Lambert and Isernia, Valentina and Ajana, Faiza and Neau, Didier and Descamps, Diane and Charpentier, Charlotte and Benalycherif, Aïda and Phung, Bao and Peytavin, Gilles and Landman, Roland and BICOLDER-IMEA 057 study group, BICOLDER-IMEA 057 study group},
  title = {Switch to bictegravir/emtricitabine/tenofovir alafenamide in people living with HIV aged 65 years or older: BICOLDER study – IMEA 057},
  journal = {Journal of Infection and Public Health},
  year = {2025},
  doi = {10.1016/j.jiph.2025.102946}
}
Kostenlos starten →